Komfo Anokye Teaching Hospital
Kumasi, Ashanti Region, Ghana
Location status: Recruiting
NCT Number: NCT07100561
In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Kumasi, Ashanti Region, Ghana
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.
Time frame: 90 days
the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization
Time frame: 90days
The readmission rate of heart failure patients on guideline-directed medical therapy (GDMT) will be compared to those who are not on GDMT.
Time frame: 90days
Quality of life at 90 days will be measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Time frame: 90 days
. Assessing all-cause mortality will involve tracking total deaths from any reason within a population over the 90-day follow-up
Time frame: 30 days
Caregiver burden will be assessed using the standard tool "Caregiver Burden Questionnaire - Heart Failure Version 3.0 (CBQ-HF)
Contact information is provided by the study sponsor or research team.
Komfo Anokye Teaching Hospital
Other
Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission- A Pilot Randomized Control Trial
Acronym: HeFRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06008197
Acute Heart Failure, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07098858
Cardiovascular Diseases, Heart Diseases
Jonesboro, Arkansas, United States
View Trial DetailsNCT07491237
Arrhythmia, Arrhythmias, Cardiac
Roma, Italy
View Trial DetailsNCT06024746
Cardiovascular Diseases, Heart Diseases
Fairhope, Alabama, United States
View Trial Details